Menu Back toSpeakers

Medical Affairs and Scientific Communications Forum

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!


Speakers

  • Dannis  Chang, PharmD

    Dannis Chang, PharmD

    • Executive Director, Head of Medical Capabilities
    • Mirati Therapeutics , United States

    Dannis Chang is currently the Executive Director and Head of Medical Affairs Capabilities at Mirati Therapeutics, where he is responsible for leading strategic efforts for implementation of Medical Information and Communication services, overall medical operations infrastructure, policies, technical information and procedures, as well as delivering the development and execution of medical education and sponsorship efforts, congress management and internal training efforts across the organization. He received a doctorate of pharmacy degree from University of Southern California and a post-doctoral fellowship from Rutgers University.

  • Amy  Van Sant, PharmD, MBA

    Amy Van Sant, PharmD, MBA

    • President, Medical Affairs
    • Ashfield Engage, United States

    With nearly 20 years of experience in the healthcare and pharmaceutical industry, Amy has held various roles of increasing responsibility within the areas of Medical Affairs and Regulatory. As the current head of US Medical Affairs, she is responsible for developing, communicating and driving strategy and leading the organization to success with a prioritized focus on the design and delivery of MI and MSL programs. Prior to joining Ashfield, Amy spent more than 10 years at Johnson & Johnson supporting the biopharmaceutical business in the areas of Immunology, Infectious Diseases, Vaccines, Global Public Health, Strategic Customer Group (Market Access), Established Products Group, and the Research & Development areas.

  • David  Meats

    David Meats

    • Associate Director, Regulatory Services Management
    • Certara Synchrogenix, United States

    David Meats is an Associate Director of global submissions and regulatory services management at Certara Synchrogenix. He has been a medical writer for approximately 20 years working in oncology, immuno-oncology, endocrinology, musculoskeletal, cardiac, hepatic, renal, and infectious disease therapeutic areas on nearly every available clinical document type. He specializes in leading and writing FDA and EMA regulatory submissions and aggregate safety reports. David is the co-chair of the DIA MASC 2022 conference, and has been a member of DIA for 7 years.

  • J. Lynn  Bass, PharmD, RPh

    J. Lynn Bass, PharmD, RPh

    • Senior Director, Medical Sciences
    • Medexus Pharma, United States

    With 20+ years of experience in Medical Science Liaison and Medical Affairs roles across the pharmaceutical industry, Lynn is currently the Senior Director, Medical Sciences at Medexus Pharma. Her industry career has spanned many therapeutic areas and she has authored/ co-authored several MSL surveys. Lynn is the elected Chair of the Medical Science Liaison Community and serves on the DIA's North America Regional Advisory Council. She is a regular, invited panelist at MSL and Medical Affairs events. Lynn holds B.S. degrees in Biology and Medical Technology. She received her B.S. in Pharmacy from the Medical College of Virginia and her Doctor of Pharmacy degree from the University of South Carolina.

  • Ruggero  Galici, PhD

    Ruggero Galici, PhD

    • Director, Nonclinical and Clinical Pharmacology Writing
    • Alexion Pharmaceuticals, AstraZeneca Rare Disease, United States

    Dr. Galici has a background in Drug Discovery and Clinical Development with expertise in Pharmacology. He has over 15 years of experience successfully and strategically planning and delivering scientific, medical communications and global regulatory submissions to support Oncology, Vaccine, Rare Disease, Neuroscience, Pain, Immunology and Inflammation, and Consumer Health (nutrition, Rx-to-OTC switch) programs. He is currently the co-chair of the DIA MASC forum.

  • Hanady  Elhadidy, PharmD

    Hanady Elhadidy, PharmD

    • Director, US MI & Global Escalations
    • Bristol Myers Squibb, United States

    Dr. Elhadidy has over 12 years of experience in the Medical Affairs and Medical Information space. She is currently leads the US Medical Information and Global Escalations team at Bristol Myers Squibb. Prior to BMS, Hanady worked with a variety of large and mid-size pharmaceutical companies in a various positions within Medical Communications and Medical Information. Prior to joining industry, Hanady worked in a community setting as a dispensing pharmacist.

  • Marie-Ange  Noue, PhD

    Marie-Ange Noue, PhD

    • Senior Director, Head of Scientific Communications
    • EMD Serono, Canada

    Marie-Ange Noue is a PhD chemist trained at Curie University in Paris and at the University of Houston. She started her career working as a research scientist in petrochemicals. She later found her niche upon joining EMD Serono in 2008, where she’s held a number of positions of increasing responsibility. In her current role as Senior Director, Head of US Scientific Communications, she provides strategic leadership and oversight for activities related to Medical Information, Medical Communication, Medical Training, and Medical Education for the US. Marie-Ange chairs the Board of Directors of the Canadian Medical information network, and serves on the Executive Board of PhactMI.

  • Sonia  Sandhu, PharmD

    Sonia Sandhu, PharmD

    • Director, Medical Information
    • Gilead Sciences, Inc., United States

    Sonia Sandhu is a Director of Global Medical Information at Gilead Sciences overseeing COVID-19 and Liver Diseases therapeutic areas. Sonia has 14 years of experience in medical information and medical affairs across multiple therapeutic areas and is actively involved in PhactMI and Patient Focused Medicines Development. She is also on the COVID-19 Patient Engagement Committee focusing on the Medical Information patient journey throughout the life cycle of remdesivir. Sonia received her Bachelor of Science in Biological Sciences from the University of California, Davis and Doctor of Pharmacy from Midwestern University.

  • Diane  Cleverley, PhD

    Diane Cleverley, PhD

    • Senior Regulatory Writer
    • Synchrogenix, a Certara Company, United States

    Dr. Cleverley has more than 20 years experience in the medical publication field, which she entered shortly after earning her PhD in Microbiology and Molecular Genetics as a joint degree from Rutgers and UMDNJ. During that time, she proposed the “glycine hinge” theory. She has contributed editorial support for publications for prestigious higher tier journals such as NEJM and JCO. Dr. Cleverley has also written award-winning patient literature, clinical trial materials, and healthcare provider education. She currently is lending her writing talents to the regulatory field. She developed a patient advocacy tool for making diagnosis more effective. Dr. Cleverley has been an active team member of AMWA, ISMPP, and MAPS, and holds a CMPP.

  • Jennie  Jacobson, PhD

    Jennie Jacobson, PhD

    • Associate Director, Publications and Scientific Communications
    • Incyte, United States

    Jennie G. Jacobson is an Associate Director, Publications and Scientific Communications at Incyte Corporation. She earned her BA from Swarthmore College, and PhD from Harvard University. Jennie conducted post-doctoral research at Upjohn Laboratories and the University of Michigan before realizing becoming a medical writer would allow her all the fun of interpreting data without the work of generating data. She rounded out her education with two AMWA certifications, a certificate in Medical Writing from U Chicago, and a CMPP certification. In her 22 years as a medical writer, Jennie has worked in oncology, mental health, health outcomes research, infectious disease, endocrinology, and respiratory and gastrointestinal disease.

  • Meera  Kodukulla, PhD

    Meera Kodukulla, PhD

    • Senior Director, Scientific Publications
    • AstraZeneca, United States

    In her current role as Head, Scientific Publications, BioPharmaceuticals R&D at AstraZeneca, Meera provides leadership in developing and shaping Publication and Communication strategies. Her experience spans all phases of drug development in multiple therapy areas. With her multi-domain expertise, Meera brings a unique advisory perspective to help build pharma publications/medical writing capabilities and process/compliance excellence. She is passionate about developing and mentoring publication professionals. Meera holds a PhD in Organic Chemistry. She is a certified emotional intelligence trainer and commits her time to mentoring and leadership development for women in Healthcare/Business/STEM.

  • Andrea Tuttle Meyers

    Andrea Tuttle Meyers

    • Senior Vice President, Medical Writing
    • Syneos Health, United States

    Ms. Meyers is the Senior Vice President of Medical Writing at Syneos Health. She has led global medical writing teams for more than two decades in both CRO and sponsor organizations. Ms. Meyers has authored documents across all phases of clinical development for pharmaceutical products as well medical devices, including regulatory dossiers and submissions. In addition, she has also led regulatory and clinical development, leading two oncology products to NDA submission and subsequent approval. Prior to her career in clinical research, Ms. Meyers practiced neuropsychology. In 2020, Ms. Meyers was honored to be named a Healthcare Businesswomen's Association Luminary in recognition of her 25+ years of service in Clinical Research.

  • Donna  Booth, PharmD

    Donna Booth, PharmD

    • Director, Field Medical HTA and Policy, US Medical Affairs
    • GlaxoSmithKline, United States

    Donna V. Booth, B.S, PharmD. is the Director of Field Medical HTA and Policy at GlaxoSmithKline. She has extensive experience across Medical Affairs as Medical Information leader aligned to various therapeutic areas as well as Payers & Policymakers; as Health Policy Liaison focused on Healthcare Quality; & as strategic initiatives lead for value evidence & outcomes. She currently leads a team of field liaisons focused on medical engagements with HTA, Quality & other Policy Organizations. Donna received her Bachelor of Pharmacy from University of Georgia & her Doctor of Pharmacy from Medical University of South Carolina. Before joining industry, Donna was a clinical pharmacist with faculty appointments at local colleges of pharmacy.

  • Danielle  Day, PhD

    Danielle Day, PhD

    • Senior Medical Director, Immunology, Rare Disease
    • Sobi, United States

    Danielle has held progressive field- and headquarters-based medical leadership roles in both large pharma and small biotech organizations including AstraZeneca, Fractyl Laboratories, Novo Nordisk and uniQure. Currently she is the Senior Medical Director for Immunology and Rare disease at Sobi. Before joining industry, Danielle held academic faculty roles at the University of Massachusetts and University of New England and was employed as a research physiologist for the U.S. Army Research Institute of Environmental Medicine. Danielle earned her M.S. and Ph.D. in Integrative Physiology from the University of Colorado in Boulder where she studied, and remains passionate about, sex differences in the research and treatment of diseases.

  • Sonja  Hokett, PharmD, MS

    Sonja Hokett, PharmD, MS

    • Executive Director/Head of Medical Managed Care
    • BioXcel Therapeutics, United States

    Sonja Hokett, PharmD MS, currently works at BioXcel Therapeutics as Head of National Medical Managed Care (MMC) Team within the Chief Development Officer organization. During her 16 years in pharma industry, Sonja has held both Field and Headquarter Medical Affairs positions (Jazz, Intercept, and Genentech). Most recently she hired and directed multiple field teams (Medical Managed Care Field Directors & Health System Medical Directors). In her headquarters positions she developed Medical Affairs Training, Operations & Specialty Pharmacy Teams.

  • Paul  Minne, PharmD, RPh

    Paul Minne, PharmD, RPh

    • Director, MSL Team
    • Neurocrine Biosciences, United States

    Paul Minne has over 20 years of experience in medical affairs within the biopharmaceutical industry. During his career, he has had substantial experience with all phases of drug development and support, multiple new product launches, and management of MSL Teams. He has earned a BS from Drake University and a Doctor of Pharmacy from the University of Colorado Health Sciences Center, is a licensed pharmacist and preceptor with the State of Colorado, and is an adjunct professor at the University of Colorado Skaggs School of Pharmacy. Paul resides in Parker, Colorado.

  • Kay  Uttech, PharmD, MA, RPh

    Kay Uttech, PharmD, MA, RPh

    • VP, Strategic Initiatives
    • Indegene, United States

    Kay Uttech is VP for Strategic Initiatives at Indegene working with companies to build and optimize medical affairs services. She has more than 20 years’ experience in the pharmaceutical and medical device industry. Kay has held roles in Medical Affairs as a MSL and leading MSL teams in North America. Additionally, she has also held other responsiiblities in Medical Communication and Information; development of global scientific knowledge management systems; grants for ISS and medical education; and promotional review. Her current work is focused on leveraging technology to drive efficiency that optimizes the medical and scientiifc expertise of Medical Affairs teams.

  • Tamei  Elliott, MS

    Tamei Elliott, MS

    • Senior Manager, Scientific Programs
    • DIA, United States

    Tamei Elliott is the Senior Manager of Scientific Programs for the Americas Region at DIA. She is responsible for identifying and prioritizing content areas and topics of importance to DIA constituents, assessing the implications of important regulatory and health policy changes, and incorporating appropriate content into the development and advancement of content for DIA conferences and courses. Prior to DIA, Tamei worked as a Regulatory Affairs Specialist where she maintained a portfolio of INDs and protocols for clients and was responsible for the preparation, tracking, and submission of regulatory documents to regulatory health authorities. She has her master's degree in biotechnology and bachelor's degree in nutritional science.

  • Stacey  Follman, PharmD, RPh

    Stacey Follman, PharmD, RPh

    • Director, Global Content Management
    • Pfizer, United States

    Dr. Stacey Follman has spent her 26-year pharmacy career at Pfizer including 15 years in the World-Wide Safety and Regulatory department in Safety Evaluation and Reporting and 11 years in Medical information. Formerly the Director, Student Affairs and currently Director, Global Content Management in Pfizer’s Global Medical Information Department . Dr. Follman has experience overseeing scholarly activities associated with approximately 10 APPE Pharmacy rotational students annually, the Student Summer Worker program and the recruitment and preceptorship of post-doctoral Fellows. In addition, she maintains internal/external partnerships, leading student/fellow initiatives with multiple scientific institutions.

  • Rebecca  Sleeper, PharmD

    Rebecca Sleeper, PharmD

    • Co-Chair Sex and Gender Summit
    • Senior Associate Dean and Professor, TTUHSC Jerry H. Hodge School of Pharmacy, United States

    Dr. Sleeper is a Professor of Pharmacy Practice in Geriatrics at the Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy, and is currently the Senior Associate Dean of Curriculum, Assessment and Accreditation. She is a Board Certified Pharmacotherapy Specialist and a Fellow of the American College of Clinical Pharmacy and the American Society of Consultant Pharmacy. She is the co-editor of the textbook Fundamentals of Geriatric Pharmacotherapy. Her focus expanded to include Sex and Gender Health education in 2011, joining the Curricular task force of the Laura Bush Institute for Women’s Health. She was a core member of the team to draft the proposed educational tenets in Sex and Gender Health Education.

  • Robert  Tamburri, PharmD, MBA

    Robert Tamburri, PharmD, MBA

    • Director, Medical Information Communication Channel
    • Janssen Scientific Affairs, LLC, United States

    Robert is Director of the Medical Information Communication Channels team at Janssen. In his current role, Rob is responsible for providing leadership in developing, shaping and implementing Medical Information Communication strategies as well as oversight of operations and related omnichannel modes of communications for the Medical Information Contact Center (internal and external) at Janssen. In addition to his 13 years of pharmaceutical industry experience, Rob also has 11 years of experience as a practicing pharmacist in various pharmacy practice settings. Rob earned his Bachelor of Science in Pharmacy from Temple University School of Pharmacy, his Doctor of Pharmacy degree from Shenandoah University, and his MBA from Drexel University.

  • Suneet  Walia

    Suneet Walia

    • CEO & Founder
    • Soterius, United States

  • Lakshmi  Ramkumar

    Lakshmi Ramkumar

    • Senior Director, Head of Medical Writing
    • Moderna, United States

  • Karen Joyce Hager, MS

    Karen Joyce Hager, MS

    • Senior Director, Clinical Research
    • Medicago, United States

    I am a Clinical Operations leader with over 15 years of experience in clinical trial execution, strategic oversight, and leadership of global clinical project teams. During my time at several Sponsor organizations I have supported a spectrum of clinical studies including studies evaluating vaccine candidates and potential treatment for rare diseases. I specialize in execution of aggressive clinical plans through successful partnership with clinical development, program teams, Contract Research Organizations (CRO), technology vendors, central lab vendors and global affiliates.

  • Payal  Desai, PharmD

    Payal Desai, PharmD

    • Associate Director, Medical Information and Knowledge Integration
    • Janssen Scientific Affairs, LLC., United States

    Payal Desai earned a PharmD degree from the University of Sciences in Philadelphia. Dr. Desai worked in community practice before transitioning to a career in pharmaceutical industry. Over 20 years, Dr. Desai served at several pharmaceutical companies. In her current role at Janssen, she is the Associate Director of Medical Information, where she is responsible for the successful launch of cardiovascular products. She provides strategic medical support, develops internal education plan, and participates in several cross-functional teams. She has mentored several Post-doc Fellows and pharmacy students throughout her career.

  • Barry  Drees, PhD

    Barry Drees, PhD

    • Senior Partner
    • Trilogy Writing & Consulting, Germany

    Barry holds a Ph.D. in molecular genetics. Following his postdoctoral work as a fellow of the NIH, he worked as a medical writer in the pharmaceutical industry for 32 years, and leading several regulatory submission teams. Barry is a frequent speaker on medical writing, statistics, and other scientific communication topics for Management Forum, the DIA, the European Medical Writers Association (EMWA) and other pharmaceutical associations. He is the former Editor-in-chief of “The Write Stuff”, the Journal of EMWA, and was the President of EMWA. He is currently a Co-founder and Senior Partner of Trilogy Writing & Consulting, continuing to personally lead submission teams as well as providing training for the industry around the world.

  • Monica  Kwarcinski, PharmD

    Monica Kwarcinski, PharmD

    • Vice President, Medical Affairs
    • Purdue Pharma L.P., United States

    Monica Kwarcinski is currently the Vice President of Medical Affairs at Purdue Pharma. In this role Monica oversees Medical Information, MSLs, Medical Communications and Strategy, Health Economic and Outcomes Research, Epidemiology, and FDA Postmarketing Requirement studies. Prior to joining Purdue Pharma, Monica held various positions of increasing responsibilities within Abbott Laboratories Medical Affairs Department. She received her PharmD from Creighton University in Omaha, Nebraska followed by a Drug Information Residency University of North Carolina, Chapel Hill and Glaxo. Monica has 25+ years of industry experience and frequently speaks on topics related to industry medical communications compliance and department processes.

  • Kajal  Patel, PharmD

    Kajal Patel, PharmD

    • Executive Medical Reviewer
    • Takeda Pharmaceuticals, Inc., United States

    Kajal is a seasoned pharmacist with 15+ years of experience in pharmaceutical and managed care sectors. She has in-depth knowledge and experience in business planning and execution of clinical strategy. Kajal serves as the lead medical reviewer for one of Takeda’s top products. She is skilled at extensive evaluation and providing strategic scientific consults on promotional patient-facing, HCP-facing, and payor-facing materials. Her diverse background ranges from launching branded social media platforms (Twitter, Facebook and YouTube), disease awareness materials, DTC TV ads, implementing CFL guidance in promotion and HCEI guardrails in payor materials, as well as implementing OPDP advisory comments.

  • Ellen  Whipple, PharmD

    Ellen Whipple, PharmD

    • Owner/Principal Writer
    • EW Associates, LLC, United States

    Ellen is the co-owner of Scientific Content Solutions, LLC and the sole proprietor of EW Associates, LLC. She was previously a director of medical communications with an agency. Ellen has experience with medical information-related documents (e.g., standard letters, FAQs, dossiers, escalated inquiries), continuing education articles, primary author publications, promotional review, payer materials, and advisory board meeting reports. As a member of AMCP Format Executive Committee, Ellen contributed to AMCP Format 4.1. She serves as a Clinical Assistant Professor at the University of Georgia College of Pharmacy. Since 2000, Ellen has been a Medical Advisor for the MS Foundation.

  • Raquel  Billiones, DrSc

    Raquel Billiones, DrSc

    • Associate Director, Medical Writing
    • Alexion Pharmaceuticals (astrazeneca Rare Disease), Switzerland

    Raquel Billiones, PhD has >25 years combined experience in scientific and clinical research. She has been a regulatory writer for >15 years, covering both pharmaceuticals and medical devices. Her core competencies include clinical trials and submissions documents, data disclosure and protection, and project and people management. Over the years, she took on a wide range of industry positions, as freelancer, as employed regulatory writer, and as head of medical writing departments in the CRO and big pharma settings. Raquel is currently editor-in-chief of Medical Writing, the official EMWA journal and is a member of the EMWA executive board and education committee. She is currently employed at Alexion Pharmaceuticals in Switzerland.

  • Carol  Heggie, RN

    Carol Heggie, RN

    • Vice President - Field Medical
    • Takeda Pharmaceuticals USA Inc, United States

    In her current role as Vice President - Field Medical, Carol provides leadership to both Medical Science Liaison and Field Medical Educator Teams at Takeda. Her scope also extends to Learning and Development and Field Operations, which allows her to build innovative approaches to Team Excellence and Leadership at all levels through use of cutting-edge technology and personalized learning strategies. In a career spanning over 25 years; Carol has also worked at Sanofi as Head of MSL. GEM Business Unit, where she deployed and led MSL teams across the globe, and at Shire where she led MSL teams through roles of increasing responsibility, ultimately in the role of Head of MSL - International.

  • Joanna  Rizos, MBA, RPh

    Joanna Rizos, MBA, RPh

    • Associate Director, Medical Affairs
    • Eli Lilly Canada Inc., Canada

    In her current role, she provides strategic leadership and oversight for activities related to Medical Information and Medical Information Digital solutions. She began her career as a community pharmacist, before joining the Pharmaceutical Advertising Advisory Board (PAAB) as an Assistant Commissioner. She joined Lilly, 21 years ago, first supporting Medical Information before holding various roles in Legal, Sales, Compliance and Medical Affairs. Joanna obtained her B.Sc. in pharmacy from the University of Toronto and her MBA from the Schulich School of Business. Joanna is also a board member of the Pharmacovigilance and Medical Information Network (PVN-MI) Canada.

  • Komal  Bawa, PharmD

    Komal Bawa, PharmD

    • Evidence Synthesis Scientist, US Medical Affairs
    • Genentech, United States

    Dr. Komal Bawa has taken on various roles in Medical Affairs at Genentech since joining in 2014. She currently focuses on evidence synthesis in the health economics and outcomes research organization, leading the dossier strategy for the portfolio. Similar to many other pharmacists, Komal started in medical communications before venturing out into other roles to broaden her experience. Prior to joining industry, she worked as an emergency medicine clinical pharmacist at UCSF and Brigham and Women's Hospital. Komal lives in San Francisco where she has been "getting to know" her family a little too well these days, but enjoys cooking with the kids, long walks with her mom, and can't wait to travel again.

  • Gary  Messplay, JD

    Gary Messplay, JD

    • Partner
    • King & Spalding, LLP, United States

    Gary Messplay is a Partner in the Washington, D.C., office of King & Spalding. He represents life sciences clients before the Food and Drug Administration (FDA), Drug Enforcement Agency (DEA), and other federal and state agencies. Mr. Messplay's practice includes regulatory and administrative law matters, clinical trials, criminal and civil enforcement matters, healthcare compliance, internal investigations, litigation, liability counseling, and transactional work related to pharmaceutical products. He has written extensively about pharmaceutical compliance issues and is a frequent speaker on regulatory and compliance matters. He is a member of the Food and Drug Law Institute, where he serves on FDLI’s Editorial Advisory Board.

  • Veejaye  Sinha, PharmD, RPh

    Veejaye Sinha, PharmD, RPh

    • Medical Review Assoc Director
    • Takeda Pharmaceuticals, United States

    Veejaye Sinha (VJ) is an Associate Director of Medical Information & Review for Takeda Pharmaceuticals U.S.A., Inc with a focus reviewing promotional and scientific materials within the bleeding disorders portfolio. Since academics, VJ has has worked in the hospital, agency, and industry settings. His 10 years across various medical organizations including publications, scientific communications, medical strategy execution, and medical information gives him an extensive foundation upon which he is able to support his current function and stakeholders in bringing transformative medicines to patients.

  • Kevin  Appareti

    Kevin Appareti

    • Senior Director, Global Medical Science Liaison
    • Royal Philips, United States

    Kevin Appareti is Senior Director, Global Medical Science Liaison in the Chief Medical Office at Royal Philips. He leads the Key Opinion Leader Program and Medical Education Program. He works across Philips’ businesses, markets, and research to build strong internal and external relationships with Key Opinion Leaders (KOLs) and influencers. Kevin partners with internal business, market, and research leaders and external KOLs to develop Strategic KOL Engagement Programs to deliver strategic guidance, leverage clinical and scientific knowledge, foster peer-to-peer relationships, and support clinical and marketing evidence development and medical education in support of Philips development of meaningful innovations.

  • Morgan  Bron, PharmD, MS

    Morgan Bron, PharmD, MS

    • Ingrezza Franchise HEOR Lead, Health Economics and Outcomes Research
    • Neurocrine Biosciences, United States

    Morgan Bron has worked in the HEOR field in various positions through all phases of drug development. She has held global, US headquarters and field based positions. She has supported the launch of 13 products in various disease areas such as diabetes, metabolism, hematology/blood disorders, CNS and neurology for both US and global departments. She has presented and published extensively and has served on various professional committees.

  • Elizabeth  Brown, MS, PMP

    Elizabeth Brown, MS, PMP

    • Director - Oncology Medical Writing
    • Merck Sharp & Dohme LLC , United States

    Elizabeth Brown is a Managing Medical Writer at Merck & Co near Philadelphia, PA. She has led regulatory projects and initiatives in the pharmaceutical industry for 20 years, first as a laboratory scientist, then a clinical researcher, and currently as a medical writer. Elizabeth brings a project management focus to her role as a regulatory medical writer with her PMP certification. With this focus, she has developed a passion for advising teams, providing strategic guidance how to deliver efficient, effective, and high-quality documents. She is a presenter and workshop leader for Lean Authoring through both AMWA and DIA, setting the industry standard for document simplification.

  • Alicia Alexander Cadogan, PharmD, RPh

    Alicia Alexander Cadogan, PharmD, RPh

    • Director, Oncology Medical Information
    • United States

    Alicia is Director and Team Lead for North America Oncology Medical Information at Pfizer Inc. Alicia has participated in the DIA Core Curriculum both as faculty and Chairperson, and in 2010 served as Chairperson for the DIA Annual March Med Comm Meeting. She has led the Fellow program for the DIA Med Comm Meeting from 2012 thru 2021. Alicia received her BS in Pharmacy from St. John’s University, and her PharmD from Albany College of Pharmacy. She spent 4 years at The University of Pittsburgh School of Pharmacy as a Nephrology Fellow and then as Assistant Professor of Pharmacy and Therapeutics. Alicia also worked in Medical Communications at Wyeth Pharmaceuticals and as Medical Director at CoMed Communications.

  • Mary  Coffey, PharmD, RPh

    Mary Coffey, PharmD, RPh

    • Senior Director, WW Scientific Content and US Market Capabilities
    • Bristol Myers Squibb, United States

  • Jennifer M Davis, PharmD, MS

    Jennifer M Davis, PharmD, MS

    • Associate Director Medical Training - Vaccines
    • Sanofi Pasteur, United States

    Jennifer Davis is the Associate Director of Medical Training for Sanofi Pasteur in the US. In this role, she is responsible for onboarding and training Medical Science Liaisons, with a goal of ensuring the scientific rigor of the US Medical team at Sanofi Pasteur. Jen joined Sanofi Pasteur as a Medical Science Liaison in 2018. Prior to that, she was a clinical pharmacist, specializing in the areas of HIV and vaccines. She was responsible for teaching the APhA Immunization Delivery program to pharmacists in Arizona, which sparked her passion for education and training. Jen holds both a BS and MS in Biology from Purdue University and received her PharmD from Midwestern University-College of Pharmacy Glendale.

  • Lisa  DeTora, PhD

    Lisa DeTora, PhD

    • Associate Professor, Director of STEM Writing
    • Hofstra University, United States

    Lisa is an assistant professor of Writing Studies at Hofstra University, where she teaches in multiple departments, including biology and chemistry. Her research interests include vaccination policy, medical humanities, publication ethics, regulatory writing, and theories of the body. As a member of the ISMPP ethics and standards committee, Lisa runs its publications subteam. Lisa has presented on topics such as authorship, ethics, ghostwriting, and data sharing at TIPPA. Her publications have appeared in various medical journals and books. A recent paper, which appeared in The International Journal of Clinical Practice, discusses the negative impact of ghostwriting on practicing physicians.

  • Charlie  Guerini

    Charlie Guerini

    • Senior Director, Global Operations and Head of Innovation
    • Alphanumeric Systems Inc., United States

    Charlie Guerini is passionate about both his love of countries and cultures across the globe and his dedication to innovation—namely artificial intelligence. It is no wonder why Alphanumeric selected Charlie to drive global intelligent automation strategy. Charlie’s track record includes multi-national operations strategy and execution, service desk operations, and site management for the likes of .idea, CIBC, and Citi. Charlie studied international business at Champlain Regional College in Quebec. He believes the key to success is trusting and learning from your employees, because they will take care of your customers. Outside of work, Charlie loves to explore nature and run along the Portugal coast line.

  • John  Jones, MBA

    John Jones, MBA

    • Information Technology SME
    • PhactMI, United States

    John Jones is an experienced IT Strategist focused on developing innovative technology solutions for unmet business needs in Life Sciences. John is currently the Founder and CEO of Entitech Solutions, a Life Sciences focused IT Software and Consulting firm. Prior to starting his company, John led Quintiles’ IT Consulting Division from 2010 – 2015 focusing on IT Advisory and Implementation services in Life Sciences. John has more than 20 years experience in developing and delivering IT Solutions for various companies, and has extensive experience in the clinical, regulatory, and commercial areas.

  • Diane  Litwinko, PharmD

    Diane Litwinko, PharmD

    • Director, Global Medical Customer Interface
    • Organon LLC, United States

    Diane Litwinko, Pharm D is currently Director, Global Medical Affairs, Global Medical Customer Interface at Organon where she has responsibility for ensuring customers have the right information and tools to support their healthcare decision making through Medical Review, Medical Information, and Designated Point of Contact activities. Prior to joining Organon, Diane worked at Merck and Schering-Plough in the medical information and has practiced Pharmacy. She received her B.S. in Pharmacy from Rutgers University School of Pharmacy and her Doctor of Pharmacy degree from Shenandoah University.

  • Gordon  Pennycook, PhD, MA

    Gordon Pennycook, PhD, MA

    • Assistant Professor, Behavioral Science, Hill/Levene Schools of Business
    • University of Regina, Canada

    Gordon Pennycook's expertise is human reasoning and decision-making and has applied this expertise to tackle the problem of online misinformation. He obtained his PhD in Cognitive Psychology in 2016 at the University of Waterloo. Prior to starting at the University Regina in 2018, he held a Social Sciences and Humanities Research Council of Canada Banting Postdoctoral Fellowship at Yale University. He has published 85 peer-reviewed articles and has received several awards, such as the Governor General’s Gold Medal and Poynter Institute’s International Fact-Checking Network “Researcher of the Year”. He was elected to the Royal Society of Canada’s College of New Scholars, Artists, and Scientists in 2020.

  • Hira  Shah, PharmD

    Hira Shah, PharmD

    • Director, Regulatory Affairs Advertising & Promotion
    • Regeneron, United States

    With 10+ years of experience in Regulatory Advertising & Promotion in the pharmaceutical industry, Hira Shah is Director of Regulatory Ad Promo at Regeneron Pharmaceuticals. She is responsible for the oversight of the Immunology, Infectious Disease and General Medicine therapeutic areas’ promotional activities, ensuring compliance with FDA & OPDP regulation and alignment with FDA guidance. Her expertise involves providing guidance on company initiatives and objectives, while maintaining compliance with regulation and acting with integrity. Hira received a doctorate of pharmacy degree from Long Island University in Brooklyn, NY and completed a two year post-doctoral fellowship from Rutgers University in partnership with Johnson & Johnson.

  • Angela  Sykes, MA, MS

    Angela Sykes, MA, MS

    • Senior Director, Team Leader; Publications Standards and Best Practices Lead
    • Pfizer, Inc., United States

    Angela Sykes is a Content & Education Director at Pfizer with nearly 20 years of experience in medical publications. She has extensive experience in many aspects of medical education, communications and publications across various therapeutic areas including: cardiovascular disease, infectious disease, autoimmune disease, diabetes, obesity, ophthalmology, psychiatry and osteoporosis.

  • Christina  Wright, PharmD

    Christina Wright, PharmD

    • MSL Lead, Director Southeast MSLs - Immunology
    • TG Therapeutics, United States

  • Raegan  McClain, JD, LLM

    Raegan McClain, JD, LLM

    • Chief Compliance Officer
    • Oyster Point Pharma, Inc., United States

    Raegan has over 20 years of legal and compliance experience working in large and specialty global pharmaceutical and medical device organizations. She began her career as an attorney in a large law firm in Chicago and has worked in small, midsized and large life sciences companies in legal and compliance roles where she was responsible for partnering with cross-functional teams to strategically build and evolve corporate healthcare compliance programs to support commercialization. She held her first in-house role at Sanofi-aventis and most recently served as Chief Compliance Officer at OptiNose US, Inc. Raegan has a B.S. from The Pennsylvania State University, a J.D. from The University of Pittsburgh and an LL.M. in Health Law from Loyola

  • Vineeth Nair Nair, PharmD, MPH

    Vineeth Nair Nair, PharmD, MPH

    • GMI Content Manager
    • Sanofi, United States

    I am a licensed Pharmacist with a Doctor of Pharmacy degree and Master of Public Health degree. I currently function as a Global Medical Information Content Manager with Sanofi Global Medical Information.

  • Katie  Bates

    Katie Bates

    • Medical Writer and Consultant
    • Whitsell Innovations, Inc., United States

  • Trishna  Bharadia

    Trishna Bharadia

    • Patient Advocate, International Speaker, Writer, Advisor and Content Reviewer
    • Patient Advocate, United Kingdom

    Multiple award-winning patient advocate Trishna Bharadia raises awareness & improves support for people affected by chronic illness. She aims to put the patient voice into the entire healthcare journey. She collaborates with organisations globally, including from industry, the third sector, and HCPs, to improve support, services and patient engagement. She writes, reviews content & is a highly sought after speaker. She advises on patient centricity & diversity issues, and is a media contributor on health. She's also a patron/ambassador for several health-related and disability-related charities and sits on various advisory committees. Awards include being a "Points of Light" recipient from the UK Prime Minister's Office.

  • Demetrius  Carter, MBA

    Demetrius Carter, MBA

    • SVP, Services Operations, Regulatory Services
    • Certara Synchrogenix, United States

    Demetrius is a Clinical Development Executive with 20+ years of drug development experience, across the pharmaceutical and medical device industries. Prior work experience includes R&D roles at Glaxo SmithKline and Pfizer. He also spent time at JNJ as a Global Trial Manager before transitioning into the CRO industry. Demetrius held roles of increasing responsibilities in Project Management, Clinical Monitoring, and Central Laboratories at both IQVIA and Syneos Health. Currently, Demetrius serves as the SVP, Regulatory Sciences at Synchrogenix, where he is responsible for Regulatory Writing and Operations. Demetrius holds a BS degree in Biological Sciences from North Carolina State University and an MBA from Fairleigh Dickinson University.

  • Roseanne P Degnan, PharmD

    Roseanne P Degnan, PharmD

    • Associate Director, Medical Information & Knowledge Integration
    • Janssen Scientific Affairs, United States

  • Michael  DeLuca, PharmD, MBA, MS, RPh

    Michael DeLuca, PharmD, MBA, MS, RPh

    • Senior Vice President of Medical Affairs
    • Eversana, United States

    Michael has 20 years of healthcare and pharmaceutical industry experience in multiple leadership roles at several pharmaceutical companies. He has extensive experience in medical information, medical communications and in supporting medical review of promotional / non-promotional materials. Throughout his career, Michael has supported multiple product launches across various therapeutic areas, including rare diseases, and he has led MI activities from both a US and global perspective. Michael has led and grown established MI teams and has built a MI department and services from the ground up. Michael's educational background includes Doctor of Pharmacy, Master of Business Administration, and Master of Science in Regulatory Affairs degrees.

  • Maureen  Feeney, PharmD, MBA, RPh

    Maureen Feeney, PharmD, MBA, RPh

    • Vice President Scientific and Medical Communications
    • Takeda, United States

    Maureen has over 20 years of experience in Medical Affairs, including leadership roles in Medical Information, Medical Communications, and Field Medical. Maureen has been with Takeda for 9 years. She is currently Vice President Medical and Scientific Communications at Takeda. Previously, Maureen was Head of Global Medical Communications at Shire. Maureen has served on various DIA program committees. Prior to Takeda, Maureen held various positions of increasing responsibility including, Director of Medical Information at GlaxoSmithKline and Head of Medical Services at Incyte. Maureen has 10 years of clinical practice and teaching experience at Thomas Jefferson University Hospital and the University of the Sciences in Philadelphia.

  • Sandeep  Gantotti

    Sandeep Gantotti

    • Associate VP, Indegene Enterprise Medical
    • Indegene Pvt Ltd, India

    Sandeep Gantotti is a clinical pharmacist by background and Associate VP, Enterprise Medical at Indegene, Pvt Ltd, a leading multinational healthcare solutions provider. He has held positions of increasing responsibility in medical information, medical communications, and medical affairs at Zeneca Pharma, GSK, and Amgen. Sandeep has participated in several DIA local champion events and industry forums such as PhactMI and MAPS to contribute to a performance-driven culture within medical affairs. He is focused today on pioneering the use of modern technologies to solving today’s challenges in content development, multichannel engagement, and demonstrating organizational value of medical affairs .

  • Mae  Kwong, PharmD

    Mae Kwong, PharmD

    • Senior Director, Medical Managed Care
    • BioXcel Therapeutics, United States

    Mae Kwong has >20 years of industry experience in remote& in-house medical affairs, currently as Senior Director, Medical Managed Care with BioXcel Therapeutics. She has been a HEOR Liaison, Director of Clinical Sciences, Medical Project Scientist, and MSL across multiple therapeutic areas working for Mesoblast, Johnson & Johnson, Kos, and Wyeth Pharmaceuticals. Before industry, Mae worked at the American Society of Health-System Pharmacists focused on ambulatory care,managed care,home and long term care. She worked at and completed an ambulatory care residency at Virginia Commonwealth University Hospitals. She started her pharmacy career at Kaiser Permanente in California. Mae received her PharmD and research fellowship from UCSF.

  • Elaine  Nadeau, PharmD

    Elaine Nadeau, PharmD

    • Senior Director, Head of US Field Medical Affairs & Medical Excellence
    • Sobi, United States

  • Sean William Ryan, MD

    Sean William Ryan, MD

    • Consultant
    • NYO - McKinsey & Company, United States

  • Samit  Shah, PharmD

    Samit Shah, PharmD

    • Associate Director, MICC Omni Channel
    • Janssen Scientific Affairs, LLC, United States

    Samit is Associate Director of the Medical Information Communication Channels team at Janssen. In his current role at Janssen, he is responsible for leading, developing, shaping and implementing Medical Information Omni-Channel Communication strategies as well as oversight of operations for the team. In addition to almost 20 years of pharmaceutical industry experience, Samit has experience in developing and launching new technologies and platforms, working on cross-functional teams, and mentoring pharmacy students. Samit earned a PharmD degree from the University of Sciences in Philadelphia.

  • Seth  Tyree, MS

    Seth Tyree, MS

    • Senior VIce President, Product Strategy
    • Stratifyd, United States

    My background is data science. I spent the first 10 years of my career conducting HEOR research to drive treatment guidelines and healthcare policy. At IBM Watson Health, I visited C-level execs at hospitals around the world, helping them understand how AI can optimize their workflow and improve outcomes for patients. At GSK, I was Director of Data Science, US Med Affairs. While there, I built a Center of Excellence for Data Science to develop and apply ML and NLP capabilities to accelerate the very manual process of mining unstructured data for insights on customers and patients. As Head of Product at Stratifyd, my remit is to grow our text analytics platform to meet market needs, with a key focus on Medical Affairs.

  • Jeff  Vaughan, PharmD, MS

    Jeff Vaughan, PharmD, MS

    • National Director, Field Medical Science
    • Ashfield Engage, United States

    Current role: National Director, Ashfield Engage, Medical Affairs. Served in medical affairs leadership for last 15 years for various small and large pharmaceutical companies covering numerous therapeutic areas. Prior to industry, I served our country as an Air Force officer over a span of 12+ years as clinical pharmacy director, treating clinician and trained expert in the fields of cardiometabolic disease, trauma medicine and internal medicine. While serving as a pharmacy director, I pioneered several pharmacy/medical school residency programs, serving as an adjunct professor at the University of Florida, LECOM and FAMU. Currently residing in Tampa, Florida, interests include podcasts and promoting the Medical Affairs profession.

  • Chris  Wasden, EdD, MBA

    Chris Wasden, EdD, MBA

    • Head of Pharma Specialty Solutions and Corporate Strategy
    • Happify Health, United States

    As Head of Happify Health’s Pharma Specialty Solutions/Corporate Strategy, Chris is leading the effort to bring Happify’s Intelligent Health platform to the pharmaceutical and healthcare industry. Recently he served as a Board Member of the Digital Therapeutic Alliance (DTA). In addition, he was a professor at the University of Utah and served as Executive Director of the Sorenson Center for Discovery & Innovation, a digital therapeutic game incubator. He is the co-author of two books on innovation, creativity, and leadership: Tension - The Energy of Innovation; and Solving for Why - Change Your Identity, Change Your Future. He is the named inventor on 12 issued patents, has been a founding leader in 10 startups.

  • Mari  Ylipelkonen Welke, MA

    Mari Ylipelkonen Welke, MA

    • Director Safety & Innovation
    • Certara|Synchrogenix, United States

  • Stephanie  Young Moss, PharmD, MS

    Stephanie Young Moss, PharmD, MS

    • Pharmacist, Owner
    • Integrative Pharmacy Outcomes and Consulting, United States

    Dr. Stephanie Young Moss received her Doctor of Pharmacy degree from Xavier University of Louisiana College of Pharmacy and a Masters of Health Services Administration with a concentration in Health Economics from The University of Wyoming. She has worked in various areas in pharmacy, Community, Regulatory Compliance, Managed Care, and Health Economics and Outcomes Research. Over the past 20 years Dr. Moss has advocated for decreasing disparities in health care through her volunteer work. She is also the owner of Integrative Pharmacy Outcomes and Consulting, which focuses on educating underserved communities on ways to reduce and prevent health disparities. This is achieved through health literacy, cultural competency, and technology.

  • Colin  Baughman, MBA

    Colin Baughman, MBA

    • Managing Partner and Founder
    • True North Solutions Inc., United States

    Colin Baughman leads True North, a Medical Affairs Analytics & AI consulting practice based in Cambridge, Massachusetts, USA. His team has worked across more than 25 conditions and over 100 projects ranging from use of AI for Medical Information, deep learning for advisory board insights, neural networks in social media monitoring, claims-based patient landscaping & access models, Medical Education unmet need prediction, scientific congress analytics using NLP, chat bots, and other programs. In addition, the True North team has led development of several digital health partnerships (including study design) in areas such as voice biomarkers, keystroke signatures, and wearables for disease identification and recurrence.

  • Rachel  Couchenour, PharmD, MBA

    Rachel Couchenour, PharmD, MBA

    • VP, Head of Medical Affairs
    • Travere Therapeutics, United States

    Rachel Couchenour, PharmD, MBA is a Medical Affairs leader with over 20 years experience in the biotech and pharmaceutical industry. She currently serves as Vice President, Global Medical Affairs at Travere Therapeutics, accountable for building and executing the medical affairs strategy for both commercial and pipeline products at this biopharmaceutical company. Previous experience includes Head of US Medical Affairs at AveXis / Novartis Gene Therapy, Field Leadership at Lundbeck & Chelsea, and advocacy / healthcare policy roles at Sanofi. Prior to joining the industry she was in academia with clinical practice in ambulatory care. BS in Pharmacy, UNC-Chapel Hill; DrPharm-Medical University of South Carolina; MBA-Drexel.

  • Sophie Forge Forge, MS

    Sophie Forge Forge, MS

    • Global Head of Medical Data to Insights
    • GSK, United States

    Sophie Forge leads GSK's Medical Data to Insights group, which mission is to infuse GSK's medical strategies and tactics with voice of the customer(VoC)-based insights. Sophie spent most of her career in technology, building and implementing Machine Learning (ML) / Natural Language Processing (NLP) platforms and solutions that deliver business value and growth. Prior to joining GSK, Sophie worked at IQVIA Technologies, where she led the development and commercialization of a "Next best" intelligent platform, and at Elsevier, where she led the Smart Content team, applying NLP to medical content to power better search, retrieval and content creation.

  • Eileen  Girten, MS

    Eileen Girten, MS

    • Director, Medical Writing
    • Pfizer Inc, United States

    Eileen M. Girten is Director of Medical Writing at Pfizer and is experienced in regulatory and publications writing, submissions, and mentoring. She is an Adjunct Assistant Professor at the University of the Sciences in Philadelphia and has taught Regulatory Documentation Processes for the Biomedical Writing program. Eileen earned a BA in Chemistry from Rosemont College, an MS in Psychology from Saint Joseph’s University, and an MS in Biomedical Writing from the University of the Sciences in Philadelphia.

  • Darshan  Kulkarni, JD, PharmD, MS

    Darshan Kulkarni, JD, PharmD, MS

    • Principal Attorney
    • The Kulkarni Law Firm, United States

    Dr. Kulkarni is Principal Attorney for the Kulkarni Law Firm which focuses on providing legal and regulatory solutions to pharmaceutical companies and their providers. He is a pharmacist & lawyer and advises clients on bringing their product to market, focusing on post IND thru commercialization and genericization.

  • Sara  Parambil, PharmD

    Sara Parambil, PharmD

    • Associate Director, MI Engagement and Established Brand Lead
    • AstraZeneca, United States

    Sara has been working at AstraZeneca in Medical Information for various brands and roles for 11 years. In her current role, she serves as the MI Engagement & Established Brands Lead with a specific focus on increasing engagement globally with local market MI teams. She also leads in creating onboarding guides and other valuable resources for local market MI teams, maintaining guidances/SOPs, and assisting with divestments and acquisitions. She graduated from University of the Sciences in Philadelphia with a Pharm.D. and completed a Clinical Pharmacy residency at Christiana Hospital in Delaware. Prior to joining AstraZeneca, she worked at Wyeth Pharmaceuticals in Medical Information and in Publications.

  • Felicity Katherine Poole

    Felicity Katherine Poole

    • Commissioning Editor
    • Taylor and Francis, United Kingdom

    Felicity Poole is a Commissioning Editor for the publisher Taylor & Francis. She has worked across a range of therapy areas in T&F's extensive medical portfolio, including their Dove Medical Press titles. She currently manages Expert Review of Vaccines, and Expert Review of Anti-infective Therapy, part of the Expert Collection series. The Expert Collection is an authoritative reference point for research, spanning the entire drug development pipeline from drug discovery to post-launch marketing surveillance and drug safety, and all offer article enhancements including plain language summaries. Felicity has a keen interest in open science and ethical and transparent publishing, as well as patient engagement and plain language summaries.

  • Constance  Stangarone

    Constance Stangarone

    • Convention Services, Principal Manager
    • Genentech, United States

    Constance Stangarone is part of the Genentech Strategic Events Services Team as the Conventions Services Principal Manager. In this role, she is accountable for convention channel strategy and building an integrated customer congress experience. She previously was on the U.S. Medical Affairs Oncology Congress Team. During her time on the USMA Oncology Team she developed the 2021 congress strategy and led execution of medical education booth materials. This includes approaches for AACR and ASCO to deliver a cohesive customer engagement and trying to identify new ways for medical engagement for congresses. She earned her bachelor’s degree from Villanova University with a major in psychology and minors in business and cognitive science.

  • Carol  Vu

    Carol Vu

    • Thought Leader Liaison Director
    • Sobi, United States

  • Christy  Cheung, PharmD, RPh

    Christy Cheung, PharmD, RPh

    • Medical Science Liaison
    • Sanofi Genzyme, Canada

    Christy is a Medical Science Liaison, Neurology at Sanofi and co-founder of the AI Collective. She graduated from the University of British Columbia in Canada in 2019 and subsequently completed a Medical Affairs Fellowship. As a digital health enthusiast, she has attended a number of healthcare hackathons, which fuelled her initial curiosity for digital health and led to the beginning of her now passion projects. Aside from her work as an MSL at Sanofi, she also acts as a digital project lead and plays an active role in a volunteer digital innovation group within the organization. Christy has been invited to speak at conferences such as DHX Virtual and as a guest lecturer on the topics of digital health and artificial intelligence.

  • Truc  Dinh, PharmD

    Truc Dinh, PharmD

    • Senior Manager, Medical Information
    • Gilead Sciences, Inc., United States

    Truc Dinh is a Senior Manager in Medical Information at Gilead Sciences where she is responsible for managing global and US medical information activities for the COVID-19 and Liver Diseases therapeutic areas. She received a Bachelors of Art degree in Public Health and Public Policy from University of California, Berkeley and a Doctor of Pharmacy degree from University of California, San Francisco with an emphasis on the Health Sciences and Policy Management pathway. She completed her postdoctoral fellowship in Medical Information with Gilead Sciences and University of Southern California.

  • Shannon  LaMey, BSN, MS

    Shannon LaMey, BSN, MS

    • MSL Field Director, Neuroscience, US Medical Affairs
    • Genentech, Inc., United States